Genito-urinary Drugs Market Global Briefing 2017Including: Hormonal contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign prostatic hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and DiureticsCovering: Daiichi Sankyo Company, Limited, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc., Sanofi S.A.
The global genito-urinary drugs market is expected to reach around $75 billion in 2020. This growth is mainly due to the growing genitourinary disorders like chronic kidney disease CKD and also going forward, the number of pipeline drugs (ABT-614, Abbott Laboratories and EOS789, Chugai Pharmaceutical) are expected to increase with constant improvements in healthcare infrastructure.
Genito-urinary Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.
Reasons to Purchase
- Get up to date information available on the genito-urinary drugs market globally.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Genito-urinary Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the genito-urinary drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the genito-urinary drugs market and suggests approaches. Scope
Markets Covered: Hormonal contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign prostatic hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and Diuretics
Companies Mentioned: Daiichi Sankyo Company Limited, Pfizer Inc., Bayer AG, Astellas Pharma Inc., Allergan Plc., Otsuka Pharmaceutical Co., Ltd., GlaxosmithKline Plc., Sanofi S.A.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.